-
-
Toggle navigation
Frontiers reaches 6.4 on Journal Impact Factors
Submit your manuscript
Scope
Section RNA probes structural and regulatory aspects of all RNAs, both coding and non-coding, via experimental and computational approaches; and publishes cutting-edge basic, translational, and clinical research findings in RNA biology — in particular, those employing the latest technologies to identify RNA-based diagnostics and therapeutics.
Scope
Serving as an international forum for rapid publication of cutting-edge basic, translational, and clinical research findings, section RNA crosses disciplines within the RNA family and probes structural and regulatory aspects of coding and non-coding RNA (ncRNAs), tRNAs, rRNAs, snoRNAs, microRNAs, siRNAs, piRNAs, pRNAs, tel-sRNAs, long ncRNAs, and more.In its biological aspect, it covers a range of subjects in all areas of research into RNA structure and function, including biogenesis; viral and body fluid RNA metabolism; RNA catalysis, RNA-binding proteins, RNA editing, and RNA splicing and translational control; as well as the role of RNAs in gene regulation and genome defense.
In its chemical, computational, and advanced technological aspects, it covers RNA chemistry, epigenomics, and computational biology; innovative findings from next-generation sequencing and single-cell analysis; and detection of RNA with flow cytometry and other quantitative methodologies.
RNA, in all its variety, provides command and control over cells, and the involvement of mutations or imbalances in the RNA repertoire in human diseases is increasingly appreciated. Thus, one of the key themes of section RNA is to serve as a strong platform for dissemination of translational and clinical research on RNA for its application at the patient’s bedside. The scope of the section thus covers RNA-based diagnostics and therapeutics, as well as any and all diseases in which RNA may be used for diagnosis, monitoring, and prognosis. In addition, topics concerning RNA stability and turnover, in vitro evolution, epigenetics, and biomedical studies of RNA are also welcomed.
Our ultimate goal is to accelerate communication in the field, as well as to stimulate scientific and medical investigation into all aspects of RNA science.
Indexed in: PubMed, PubMed Central, Scopus, Google Scholar, DOAJ, CrossRef, Chemical Abstracts Service (CAS), EMBASE, AGRICOLA, Semantic Scholar, Ulrich's Periodicals Directory, Science Citation Index Expanded, BIOSIS Citation Index, Biological Abstracts, CLOCKSS, EBSCO, OpenAIRE, Zetoc
PMCID: all published articles receive a PMCID
RNA welcomes submissions of the following article types: Book Review, Correction, Data Report, Editorial, General Commentary, Hypothesis and Theory, Methods, Mini Review, Opinion, Original Research, Perspective, Protocols, Review, Specialty Grand Challenge, Systematic Review and Technology Report.
All manuscripts must be submitted directly to the section RNA, where they are peer-reviewed by the Associate and Review Editors of the specialty section.
Articles published in the section RNA will benefit from the Frontiers impact and tiering system after online publication. Authors of published original research with the highest impact, as judged democratically by the readers, will be invited by the Chief Editor to write a Frontiers Focused Review - a tier-climbing article. This is referred to as "democratic tiering". The author selection is based on article impact analytics of original research published in all Frontiers specialty journals and sections. Focused Reviews are centered on the original discovery, place it into a broader context, and aim to address the wider community across all of Genetics and Molecular Biosciences.
Frontiers Editorial Office
Avenue du Tribunal Fédéral 34
CH – 1005 Lausanne
Switzerland
Tel +41(0)21 510 17 40
Fax +41 (0)21 510 17 01
Frontiers Support
Tel +41(0)21 510 17 10
Fax +41 (0)21 510 17 01
support@frontiersin.org
There are no results to display.
Click on any of the keywords to find further editors related to it.
- Article(s) found
- Latest
- Most viewed
This section has no articles.
There are no articles to display. Please try changing the filters.
- Research Topic(s) found
- Latest
- Most viewed
Contact Editorial Office
Avenue du Tribunal Fédéral 34
CH – 1005 Lausanne
Switzerland
Tel +41(0)21 510 17 40
Fax +41 (0)21 510 17 01
Tel +41(0)21 510 17 10
Fax +41 (0)21 510 17 01